Detailed FundamentalsSingle-page fundamentals layout — broad valuation, growth, profitability, health, competitors, top funds & analyst detail.
Back to Quotes search
ILMNIllumina Inc Live data
$271.90▲ +1.90 (0.7%%)as of Sep 29, 2026, 1:11 AM UTC
Price chartUnavailable
Loading price history...
52-Week Range
Trailing twelve months
$88.00$277.95
Daily Price Range
Day up 0.7%%
$262.89$275.69
Volume
vs 3M avg
3M3M avg
Profile
Identity and capital structure
SectorEquity
IndustryCommon Stock
Market Cap$41.1B
Short % of Float—
Employees—
Sales—
Shares Outstanding151,011,401
IPO Date—
Last Reported Qtr.—
Next Qtr. Report—
Headquarters—
Homepagewww.ilmn.com
Illumina Inc — Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenat….· via yahoo
Warnings
1 signal
Live
- Price 209% above 52-week low — momentum stretched
Scores
0–100 · higher is better except where noted
Value
—
Growth
—
Quality
—
Sentiment
—
Insider Sent.
—
Piotroski F
—
Altman Z
—
Consensus rating unavailable — no analyst coverage on file for ILMN.
Price targets unavailable — no 12-month targets on file for ILMN.
Valuation Engine
DCF Intrinsic Valuation Model
Run an interactive 5-year Discounted Cash Flow valuation on ILMN, calculate Margin of Safety, and stress-test WACC discount hurdles.
Data as ofQuote: Live · Insiders: Live · Fundamentals/Benchmarks: Curated · Vantage Composite · 1 warnings surfacedSep 29, 2026, 1:11 AM UTC